Diagnosis and Percutaneous Treatment of Biliary Tract Diseases

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 14, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
GallstoneBiliary StrictureBiliary Diseases
Interventions
PROCEDURE

Percutaneous cholangioscopic-assisted treatment

The intervention administered is a percutaneous colangioscopic assisted technique that uses endoscopic Spyglass system. The endoscopic Spyglass system is designed to provide direct viewing and to guide both optical devices and accessories for lithotripsy in case of litiasic pathology and is equipped with a suitable bioptic clamp in case of biopsy collection. The use of the digital Spyglass catheter involves the preliminary percutaneous puncture of the bile ducts with a right, left or combined approach, and the subsequent execution of a cholangiographic study. Additional treatment sessions may be performed every 15-20 days in case of residual lithiasis. At the end of each session, an internal-external transeptic percutaneous drainage (ptbd) of adequate caliber (8-14 fr) is left in place to monitor any complications and maintain a route of access for sequential treatments.

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER